https://www.pharmanow.live/latest-news/eli-lilly-fda-approval-onswik-once-weekly-basal-insulin-type-2-diabetes 2026-09-25T11:21:22+05:30 Pharma Now en 2026-09-25T00:00:00+05:30 Eli Lilly Gains FDA Approval For Onswik Once-Weekly Insulin Eli Lilly https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e675a77c-f0de-4572-aff6-73065c912ea1/fa83483f-0497-4b9b-abff-0d48d71b081a.png https://www.pharmanow.live/latest-news/zenzi-pharmaceutical-import-alert-66-79-fda-704a4-records-requests 2026-09-25T11:21:18+05:30 Pharma Now en 2026-09-25T00:00:00+05:30 Zenzi Pharma Gets Import Alert 66-79 After Ignoring FDA Requests Zenzi Pharma https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e675a77c-f0de-4572-aff6-73065c912ea1/30f6254f-3a23-4fec-ac34-28b243bea9d4.png https://www.pharmanow.live/latest-news/merck-fda-approval-belzutifan-lenvatinib-advanced-ccrcc 2026-09-25T11:21:11+05:30 Pharma Now en 2026-09-25T00:00:00+05:30 Merck Gains FDA Approval For Kidney Cancer Drug Combination Merck https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e675a77c-f0de-4572-aff6-73065c912ea1/1052612f-0289-457f-aca8-14cb4e060c16.png https://www.pharmanow.live/latest-news/fda-bsufa-reauthorization-public-meeting-october-2026 2026-09-25T11:21:29+05:30 Pharma Now en 2026-09-25T00:00:00+05:30 FDA Opens BsUFA Comments Ahead Of October 2026 Meeting FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e675a77c-f0de-4572-aff6-73065c912ea1/4796b622-dea4-43da-aee2-42c32fe8f77a.png https://www.pharmanow.live/latest-news/becton-dickinson-class-i-correction-kits-huons-sodium-chloride-ampules 2026-09-25T11:27:40+05:30 Pharma Now en 2026-09-25T00:00:00+05:30 Becton Dickinson Issues Class I Recall For Huons Kits Becton Dickinson https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e675a77c-f0de-4572-aff6-73065c912ea1/f0ecba30-5c69-4eac-9c29-5834d8e4b49a.png https://www.pharmanow.live/latest-news/ritedose-expands-bfs-capacity-fda-resolves-albuterol-shortage 2026-09-25T11:22:50+05:30 Pharma Now en 2026-09-25T00:00:00+05:30 Ritedose Expands Capacity As Albuterol Shortage Ends Ritedose https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://ml.globenewswire.com/Resource/Download/adc8d035-029c-44ec-bbcc-336e359dc315 https://www.pharmanow.live/latest-news/elicio-therapeutics-esmo-2026-amplify-7p-phase-2-pancreatic-cancer-data 2026-09-25T11:21:25+05:30 Pharma Now en 2026-09-25T00:00:00+05:30 Elicio Wins ESMO 2026 Oral Slot For Phase 2 Cancer Data Elicio Therapeutics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e675a77c-f0de-4572-aff6-73065c912ea1/5066d378-2f24-4ee8-b934-e9ac8e3e72a2.png https://www.pharmanow.live/latest-news/adarx-pharmaceuticals-ipo-abbvie-private-placement-sirna 2026-09-25T11:25:55+05:30 Pharma Now en 2026-09-25T00:00:00+05:30 ADARx Wins $535M In IPO And AbbVie Private Placement ADARx https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e675a77c-f0de-4572-aff6-73065c912ea1/916d2232-5e49-4605-8853-ee5c9b9371e3.png https://www.pharmanow.live/latest-news/nuvectis-gains-china-cde-breakthrough-therapy-designation-nxp200-braf-mutant-high-grade-glioma 2026-09-25T11:23:59+05:30 Pharma Now en 2026-09-25T00:00:00+05:30 Nuvectis’ NXP200 Wins Breakthrough Status In China Nuvectis https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e675a77c-f0de-4572-aff6-73065c912ea1/fa5d3126-816c-4f29-a3be-d32a9033f18e.png https://www.pharmanow.live/latest-news/kyverna-therapeutics-miv-cel-one-year-data-bla-submission-2026 2026-09-25T11:24:57+05:30 Pharma Now en 2026-09-25T00:00:00+05:30 Kyverna’s Miv-Cel Shows 1-Year Data Ahead Of Q4 BLA Kyverna https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e675a77c-f0de-4572-aff6-73065c912ea1/723cbe38-f97b-4566-aada-c5f8bcea4ccb.png https://www.pharmanow.live/latest-news/pharma-now-debuts-inside-cdmo-series-with-hipras-managing-director-eduard-viladesau 2026-09-25T04:42:23+05:30 Pharma Now en 2026-09-25T04:42:21+05:30 Pharma Now Debuts “Inside CDMO” Series With HIPRA's Managing Director Eduard Viladesau CDMO, Inside CDMO podcast, Eduard Viladesau HIPRA, CDMO launch story, HIPRA Biotech Services, Pharma Now podcast premiere, biologics CDMO, EU GMP fill-and-finish, CPHI Milan 2026 https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/EduardViladesauPodcastThumbnail20260925043943.png https://www.pharmanow.live/latest-news/pharma-now-launches-global-conversation-series-with-cdmo-leaders-to-decode-the-industrys-next-chapter 2026-09-25T04:42:55+05:30 Pharma Now en 2026-09-24T00:00:00+05:30 Pharma Now Launches Global Conversation Series With CDMO Leaders to Decode the Industry's Next Chapter https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/inside_cdmo_podcast_press_release20260924214139.png https://www.pharmanow.live/latest-news/telix-itm-radiopharma-merger 2026-09-23T15:34:19+05:30 Pharma Now en 2026-09-23T00:00:00+05:30 Telix ITM Radiopharma Merger Agreement Announced telix itm radiopharma merger, Telix, ITM, radiopharmaceutical, lutetium-177, isotope manufacturing, theranostics, neuroendocrine tumours https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/telix_itm_radiopharmaceutical_merger20260923151939.webp https://www.pharmanow.live/latest-news/bespak-upperton-nasal-partnership 2026-09-23T15:11:59+05:30 Pharma Now en 2026-09-23T00:00:00+05:30 Bespak and Upperton Partner on Nasal Drug Development nasal drug developmen, Bespak, Upperton, nasal drug delivery, nose-to-brain, CNS therapies, drug-device combination, nasal formulation, clinical manufacturing https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/bespak_upperton_nasal_partnership20260923150445.webp